Abstract
Purified human native third component of complement, C3, was found to inhibit in vitro natural killer (NK) cell cytotoxicity in both mouse and human systems. The effect was dose and time dependent, a 50% inhibition being reached with 190 nM C3 (35 micrograms/ml) added during the NK assay or after a 30-min preincubation of the effector cells with this C3 concentration. C3 was shown to act at the effector-cell population level because pretreatment of the target cells did not modify the NK lysis. The inhibition was not due to general cytotoxicity nor to cell agglutination. Moreover, another in vitro cytotoxicity system (represented by alloreactive cytotoxic lymphocytes) was not affected by purified C3. Structural analysis of the active part of the C3 molecule shows that the C3-induced inhibition is supported by the C3a fragment. Release of carboxyl-terminal arginine residue by carboxypeptidase B, converting C3a into des-Arg77-C3a, did not alter the inhibitory effect displayed by this fragment. These results suggest that C3a may play an important role in the regulation of NK activity.
References
Aug 15, 1975·International Journal of Cancer. Journal International Du Cancer·R B HerbermanD H Lavrin
Jul 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·S K Law, R P Levine
Jan 1, 1979·Immunological Reviews·R Kiessling, H Wigzell
Apr 17, 1979·Biochemistry·B F TackJ W Prahl
Jun 29, 1978·Nature·M GidlundI Gresser
Oct 5, 1976·Biochemistry·B D Tack, J W Prahl
May 7, 1976·Analytical Biochemistry·M M Bradford
Feb 1, 1967·Proceedings of the Society for Experimental Biology and Medicine·V J StecherG J Thorbecke
Oct 1, 1973·European Journal of Immunology·M H JuliusL A Herzenberg
May 1, 1969·The Journal of Experimental Medicine·V A BokischC G Cochrane
Aug 1, 1980·Cellular Immunology·G Cudkowicz, P S Hochman
Dec 21, 1981·FEBS Letters·M BarelR Frade
May 1, 1982·The Journal of Experimental Medicine·E L MorganT E Hugli
Apr 1, 1982·European Journal of Immunology·C CharriautR Frade
Jan 1, 1980·Journal of Immunological Methods·G D Ross
Jun 1, 1981·The Journal of Experimental Medicine·D T FearonG G Thomson
Jan 1, 1980·Journal of Immunological Methods·T Timonen, E Saksela
Citations
Dec 1, 1984·Molecular Immunology·A ErdeiM P Dierich
Jan 1, 1985·Immunology Letters·Z Fishelson
Dec 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·G F BurnsI R Mackay
Aug 1, 1983·The Journal of Experimental Medicine·M J Polley, R L Nachman
Oct 12, 2012·PloS One·Mercedes Nancy MunkondaKatherine Cianflone
Mar 31, 2010·Seminars in Hematology·George J Weiner
Oct 8, 2015·Critical Reviews in Oncology/hematology·Narges SeyfizadehSara Huerta-Yepez
Oct 30, 2008·Clinica Chimica Acta; International Journal of Clinical Chemistry·Kathleen DeiterenAnne Marie Lambeir
Apr 27, 2012·European Journal of Immunology·Xiaoping QingJane E Salmon
May 20, 2015·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·Jing WuKatherine Cianflone
Oct 18, 2003·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Karen FrancisPhilippe Gasque
Feb 1, 1994·Cancer Immunology, Immunotherapy : CII·C ScheidP L Stern
Oct 18, 2015·The Journal of Immunology : Official Journal of the American Association of Immunologists·Stefanie DererThomas Valerius
Jan 24, 2003·The Journal of Biological Chemistry·David KalantPeter N Monk